pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 0 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 17 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07105709: Open-label Extension Study in Participants With Early Alzheimer's Disease

Sponsor: GlaxoSmithKline. Phase: PHASE2. Conditions: Alzheimer's Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05634499: A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer

Sponsor: Hoffmann-La Roche. Phase: PHASE2. Conditions: Endometrial Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT02754544: Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Brain Neoplasm, Metastatic Malignant Neoplasm in the Brain, Recurrent Brain Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT05665244: Laryngeal Cryotherapy for Refractory Neurogenic Cough

Sponsor: University of Texas Southwestern Medical Center. Phase: . Conditions: Upper-Airway Cough Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07431034: Internet-Based Cognitive Behavioral Therapy for Insomnia in Persian-Speaking Adults

Sponsor: Rasool Hamidi Choolabi. Phase: NA. Conditions: Insomnia Disorder, Chronic Insomnia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06575699: Rectus Sheath Block for Analgesia After Gynecological Laparotomy

Sponsor: Duke University. Phase: PHASE4. Conditions: Gynecologic Surgical Procedures

full page →ctgov ↗
›COMPLETEDphase readoutNCT04736199: Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer

Sponsor: Bayer. Phase: PHASE3. Conditions: Prostatic Neoplasms

full page →ctgov ↗
›RECRUITINGphase readoutNCT06346132: Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

Sponsor: Schlotterbeck Hervé. Phase: NA. Conditions: Virtual Reality, Medical Device, Local Anesthesia, Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07627763: Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease

Sponsor: Initiatives Bronchopneumopathie Chronique Obstructive (BPCO). Phase: . Conditions: COPD

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07047521: A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults

Sponsor: Takeda. Phase: PHASE3. Conditions: Dengue Fever

full page →ctgov ↗
›RECRUITINGphase readoutNCT07019116: Efficacy of Artificial Intelligence for Gatekeeping in Referrals to Specialized Care

Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Primary Care, Primary Care Patients With Chronic Conditions

full page →ctgov ↗
›COMPLETEDphase readoutNCT06275906: Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis. Phase: NA. Conditions: NAFLD, Obesity, IBS

full page →ctgov ↗
›RECRUITINGphase readoutNCT07299006: Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children.

Sponsor: Fondation Lenval. Phase: NA. Conditions: Pain Management

full page →ctgov ↗
›COMPLETEDphase readoutNCT07051304: Video-Based Versus Numerical Pain Assessment in Postoperative Patients: A Pilot Study

Sponsor: Kanuni Sultan Suleyman Training and Research Hospital. Phase: . Conditions: Pain Assessment Scales

full page →ctgov ↗
›RECRUITINGphase readoutNCT05446584: Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History

Sponsor: University of Texas Southwestern Medical Center. Phase: PHASE2. Conditions: Mild Cognitive Impairment, Amnestic Mild Cognitive Disorder, Amnestic Mild Cognitive Impairment, Mild Traumatic Brain Injury, Concussion, Brain

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07318584: Cefotetan Therapy for Escherichia Coli Infections

Sponsor: Oregon Health and Science University. Phase: PHASE2. Conditions: E Coli Infection, ESBL Producing E.Coli

full page →ctgov ↗
›RECRUITINGphase readoutNCT07218133: Trans-Auricular Stimulation for Postoperative Inflammation in Spine Surgery

Sponsor: Alexander T. Yahanda. Phase: NA. Conditions: Spinal Fusion, Hyperglycemia, Postoperative Pain Management, Postoperative Care, Spine Disease, Neurologic Deficits, Neurological Disorder, Inflammation, Spine Condition, Spinal (Fusion) Surgery, Cytokine Levels, Spine Fusion

full page →ctgov ↗
›COMPLETEDphase readoutNCT03602833: Phase I Study Compound 451238 and Radiotherapy in Soft-tissue Sarcoma

Sponsor: Royal Marsden NHS Foundation Trust. Phase: PHASE1. Conditions: Soft-tissue Sarcoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07586033: Prevalence and Functional Impact of Hand and Wrist Symptoms in Ice Hockey Players

Sponsor: Dalarna County Council, Sweden. Phase: . Conditions: Hand, Wrist, Overuse Injury, Ice Hockey Players

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07462533: Assess Efficacy of a Nanodiamond Periprocedural Skin Care Regimen for Ablative Resurfacing

Sponsor: Goldman, Butterwick, Fitzpatrick and Groff. Phase: PHASE2. Conditions: Skin Laxity

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04279847: Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms

Sponsor: Incyte Corporation. Phase: PHASE1. Conditions: Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome, Myeloproliferative Neoplasm, Relapsed or Refractory Primary Myelofibrosis, Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis), ET (Essential Thrombocythemia)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06627647: A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Non-squamous Non-small Cell Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07439848: Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

Sponsor: PT. Prodia Stem Cell Indonesia. Phase: PHASE1. Conditions: Acute Respiratory Distress Syndrome

full page →ctgov ↗
›COMPLETEDphase readoutNCT07580248: Effects of Supplementation on Performance in Football Players

Sponsor: Krzysztof Mizera. Phase: NA. Conditions: Physical Performance, Cognitive Performance

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06641765: Continuous Glucose Monitoring in Dialysis Patients With Diabetes

Sponsor: Bo Feldt-Rasmussen. Phase: NA. Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Continuous Glucose Monitoring, Haemodialysis, Peritoneal Dialysis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05319067: Study of Gut Microbiota Diversity in Children Aged 1-3 Years on Prolonged Antibiotic Prophylaxis for Grade 3 or Higher Vesicoureteral Reflux Compared With 2 Age-matched Control Groups

Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Vesicoureteral Reflux 3

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04150900: 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

Sponsor: University of Maryland, Baltimore. Phase: PHASE2. Conditions: Squamous Cell Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06053411: Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac

Sponsor: Washington State University. Phase: EARLY_PHASE1. Conditions: Interaction

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05694871: Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE2. Conditions: Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Unresectable Dedifferentiated Liposarcoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06845371: MELODY Registry Follow-Up Study

Sponsor: University Hospital Tuebingen. Phase: . Conditions: Congenital Heart Disease (CHD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06377371: Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Sponsor: Weill Medical College of Cornell University. Phase: PHASE4. Conditions: Meningioma

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06497764: Evaluating Vibrational Anesthesia in Scalp Platelet Rich Plasma (PRP)

Sponsor: NYU Langone Health. Phase: NA. Conditions: Alopecia

full page →ctgov ↗
›COMPLETEDphase readoutNCT05362864: ZNN Bactiguard Cephalomedullary Nails PMCF Study

Sponsor: Zimmer Biomet. Phase: . Conditions: Osteotomy, Trochanteric Fractures, Sub-trochanteric Fractures, Femoral Shaft Fracture

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07633964: An Study Looking at Percutaneous Coronary Intervention Outcomes for Octogenarians

Sponsor: Gloucestershire Hospitals NHS Foundation Trust. Phase: . Conditions: Cardio Vascular Disease

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04590209: Clinical and Mechanistic Study of Patients (With COVID-19 or Not) With a Recent Acrosyndrome

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Adult Patients With Lesions on Fingers or Toes

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07516509: Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

Sponsor: AdventHealth Translational Research Institute. Phase: . Conditions: Insulin Resistance

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07446699: The Effect of Pushing Techniques Used During Childbirth on Women's Labor Duration, Pain, and Fatigue Levels

Sponsor: Cumhuriyet University. Phase: NA. Conditions: Childbirth, Duration of Labor, Labor Pains, Pushing During Childbirth, Fatigue During Childbirth

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07583732: BIS in Critically Ill Patients in ICU

Sponsor: Mahidol University. Phase: NA. Conditions: Critically Ill Patients

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07234032: An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Sponsor: Insmed Incorporated. Phase: PHASE3. Conditions: Pulmonary Hypertension, Interstitial Lung Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07630532: Virtual Reality Relaxation for Insomnia

Sponsor: Laval University. Phase: NA. Conditions: Insomnia Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT02941263: Natural History of Geographic Atrophy Associated With Age-Related Macular Degeneration

Sponsor: National Eye Institute (NEI). Phase: . Conditions: Age-Related Macular Degeneration

full page →ctgov ↗
›RECRUITINGphase readoutNCT07129993: Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Sponsor: Daiichi Sankyo. Phase: PHASE2. Conditions: Urothelial Cancer, Bladder Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06898021: The 3D Stent Study

Sponsor: CoreAalst BV. Phase: . Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention (PCI)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06414993: Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults

Sponsor: Chestnut Health Systems. Phase: NA. Conditions: Polysubstance Drug Use (Indiscriminate Drug Use)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02675114: PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis

Sponsor: Edwards Lifesciences. Phase: NA. Conditions: Aortic Stenosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00335816: Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Colorectal Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03777306: The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Multiple Myeloma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07599306: Effectiveness of a Structured Multidimensional Tele-rehabilitation Intervention in Cardiac Patients With Post-Intensive Care Syndrome (CARDIO-PICS)

Sponsor: Fondazione Don Carlo Gnocchi Onlus. Phase: NA. Conditions: Critical Illness, Post Intensive Care Syndrome (PICS), Cardiopathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01176006: Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: DOCK8 Deficiency

full page →ctgov ↗
›RECRUITINGphase readoutNCT07136584: SOS for Caregiver Wellbeing

Sponsor: Murdoch Childrens Research Institute. Phase: NA. Conditions: Mental Health, Depression and Burden in Caregivers, Anxiety Depression, Stress, Caregiver Anxiety, Parent of Child With Chronic Life-threatening Illness

full page →ctgov ↗
← prev
page 108 of 161
next →